Abstract:OBJECTIVE:To investigate the factors affecting phenotypes in the patients of methylmalonic acidemia combined with homocysteinemia cblC type with MMACHC c.609G>A homologous variant. METHODS:A retrospective study on the clinical manifestations, complications, treatment, and outcome in 164 patients of cblC type with MMACHC c.609G>A homologous variant was conducted. The patients were diagnosed by biochemical and genetic analysis from January 1998 to December 2020. RESULTS:Among the 164 patients, 2 cases were prenatally diagnosed and began treatment after birth. They are 3 and 12 years old with normal physical and mental development. Twenty-one cases were diagnosed by newborn screening. Among them, 15 cases had with normal development. They were treated from the age of two weeks at the asymptomatic period. Six cases began treatment aged 1 to 3 months after onset. Their development was delayed. One hundred and forty-one cases were clinically diagnosed. Their onset age ranges from a few minutes after birth to 6 years old. 110 cases had early-onset (78.0%). 31 cases had late-onset (22.0%). Five of them died. 24 patients lost to follow-up. Of the 141 clinically diagnosed patients, 130 (92.2%) with psychomotor retardation, 69 (48.9%) with epilepsy, 39 (27.7%) with anemia, 30 (21.3%) had visual impairment, 27 (19.1%) had hydrocephalus, 26 (18.4%) had feeding difficulties, 7 (5.0%) with liver damage, and 5 (3.5%) with metabolic syndrome. The frequency of hydrocephalus and seizures was significantly higher in the early-onset group. The urinary methylmalonic acid increased significantly in the patients with epilepsy. During the long-term follow-up, the level of plasma total homocysteine in the seizure-uncontrolled group was significantly higher than that in the seizure-controlled group, the difference had a statistical significance (P<0.05). CONCLUSION:Most of the patients with MMACHC c.609G>A homozygous variant had early-onset disease, with a high mortality and disability rate. If not treated in time, it will lead to neurological damage, resulting in epilepsy, mental retardation, hydrocephalus, and multiple organ damage. Pre-symptomatic diagnosis and treatment are crucial to prevent irreversible neurological damage. Neonatal screening and prenatal diagnosis are important to improve the outcome of the patients.

Lenticular Subluxation in a Patient with Homocystinuria Undetected by Neonatal Screening

Homocystinuria In A Family With Novel Cystathionine Beta Synthase Gene Mutations

Homocysteinemia due to MTHFR deficiency in a young adult presenting with bilateral lens subluxations

A case of multiple carboxylase deficiency presenting with skin lesions as the initial symptom induced by a novel mutation in the holocarboxylase synthetase gene

Case report: An asymptomatic mother with an inborn error of cobalamin metabolism (cblC) detected through high homocysteine levels during prenatal diagnosis

Ocular manifestations in classic homocystinuria

Ophthalmic manifestations of methylmalonic aciduria accompanied with homocystinuria

[A clinical study and analysis of congenital lenticular dislocation (35 cases)]

[Combined Methylmalonic Aciduria and Homocysteinemia with Hydrocephalus As an Early Presentation: a Case Report].

Detection of LAMA2 c.715C>G:p.R239G mutation in a newborn with raised creatine kinase: A case report

Prenatal diagnosis of combined methylmalonic acidemia and homocystinuria cobalamin C type using clinical exome sequencing and targeted gene analysis

[Peripheral nervous impairment in a patient with methylmalonic aciduria combined with hyperhomocysteinemia]

A novel ADAMTSL4 compound heterozygous mutation in isolated ectopia lentis: a case report and review of the literature

Childhood hepatolenticular degeneration combined with thin basement membrane nephropathy: a case report with literature review

A case of LSS‐associated congenital nuclear cataract with hypotrichosis and literature review

The First Chinese Case Report of Hereditary Folate Malabsorption with a Novel Mutation on SLC46A1

Combined Methylmalonic Aciduria and Homocystinuria Cblc Type of a Taiwanese Infant with C.609g>a and C.567dupt Mutations in the MMACHC Gene

Novel Compound Heterozygous Variants of the SEC23A Gene in a Chinese Family with Cranio-Lenticulo-sutural Dysplasia Based on Data from a Large Cohort of Congenital Cataract Patients

Patients with Cobalamin G or J Defect Missed by the Current Newborn Screening Program: Diagnosis and Novel Mutations.

The Follow-Up of Chinese Patients in cblC Type Methylmalonic Acidemia Identified Through Expanded Newborn Screening

[Factors Affecting Phenotypes in the Patients with MMACHC Gene C.609g>a Homozygous Variant Cblc Type Methylmalonic Acidemia Combined with Homocysteinuria].